(0)
Iris Bincovich, CEO will participate on the CBD Treatments discussion panel on Monday June 14 at 11:00AM ET.
Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - June 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the Company or Innocan ), is pleased to announce that it will participate at the Lytham Partners Summer 2021 Investor Conference on June 14 through June 16, 2021. Iris Bincovich, CEO of Innocan will participate on the CBD Treatments discussion panel alongside representatives from cbdMD, Charlotte s Web, CV Science Inc, and Avicanna on Monday June 14 at 11:00AM ET. A webcast of the presentation will be available on Innocan s website at
IRW-News: InnoCan Pharma Corporation: Innocan Pharma wird als eines von führenden CBD-Pharmaunternehmen an der Sommer-Investorenkonferenz 2021 von Lytham Partners teilnehmen boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
Innocan Pharma wird als eines von führenden CBD-Pharmaunternehmen an der Sommer-Investorenkonferenz 2021 von Lytham Partners finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
DBMR have recently added a report titled ‘Global Legal Marijuana Market Size, Share, Growth, Industry Trends and Forecast to 2028’ Report to our extensive database of reports. Our team of experts has curated the report by considering industry-relevant information related to the leading vendors, distributors, and ser.